文献速递烧伤

烧伤患者静脉血栓栓塞症发生率、危险因素与预防:一项国家创伤数据库研究

Venous Thromboembolism Incidence, Risk Factors, and Prophylaxis in Burn Patients: A National Trauma Database Study.
PubMed 文献 · J Burn Care Res · 2025-01-01

该研究查询美国国家创伤数据库2007至2021年数据,纳入326614例烧伤患者,其中5642例(1.7%)住院期间发生静脉血栓栓塞症(VTE)。VTE患者年龄更大、体重指数和总烧伤面积百分比更高,且男性更多(P < .001);吸烟史、高血压或心肌梗死病史和/或物质使用障碍是VTE的显著预测因素(P < .001)。

要点

  • 烧伤患者住院期间VTE发生率为1.7%(5642/326614)。
  • VTE患者年龄更大、体重指数和总烧伤面积百分比更高,男性更多(P < .001)。
  • 低分子肝素组VTE风险低于普通肝素组(OR 0.564,95%CI 0.523-0.607,P < .001)。

核心结论

  • 本研究揭示了烧伤患者VTE的危险因素和化学预防措施,有助于指导临床实践中的预防策略。
  • 这些知识可用于完善风险分层模型、为循证预防策略提供信息,并最终提升有VTE风险的烧伤患者的照护质量。

研究设计与样本

  • 查询美国国家创伤数据库2007至2021年数据,识别烧伤患者。
  • 采用描述性统计和多变量回归分析,探讨人口学/临床特征与VTE风险的关联,并比较不同VTE化学预防类型。
  • 共纳入326614例烧伤患者进行分析。

主要发现

  • 5642例(1.7%)患者在住院期间发生VTE事件。
  • VTE患者年龄更大、体重指数和总烧伤面积百分比更高,且男性更多(P < .001)。
  • 吸烟史、高血压或心肌梗死病史和/或物质使用障碍是VTE的显著预测因素(P < .001)。
  • 控制其他VTE危险因素后,接受低分子肝素的患者较接受普通肝素的患者VTE风险更低(OR 0.564,95%CI 0.523-0.607,P < .001)。
  • VTE化学预防启动时间较长(>6 h)与VTE显著相关(OR 1.04,95%CI 1.03-1.07,P < .001)。

临床怎么用

  • 作者认为,本研究结果有助于指导烧伤患者预防策略的实施。
  • 作者认为,这些知识可用于完善风险分层模型、为循证预防策略提供信息,并最终提升有VTE风险的烧伤患者的照护质量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Comprehensive studies on the incidence, risk factors, and prophylactic measures related to venous thromboembolism (VTE) are lacking in burn care. This study characterizes VTE risk and existing prevention measures to improve and inform overall patient care in the field of burn care on a national scale. The US National Trauma Data Bank was queried from 2007 to 2021 to identify burn-injured patients. Descriptive statistics and multivariate regression analyses were used to explore the association between demographic/clinical characteristics and VTE risk as well as compare various VTE chemoprophylaxis types. There were 326 614 burn-injured patients included for analysis; 5642 (1.7%) experienced a VTE event during their hospitalization. Patients with VTE were significantly older, had greater body mass indexes and % total body surface area, and were more likely to be male (P < .001). History of smoking, hypertension or myocardial infarction, and/or substance use disorder were significant predictors of VTE (P < .001). Patients who received low molecular weight heparin were less likely to have VTE compared to patients treated with heparin when controlling for other VTE risk factors (odds ratio [OR]: 0.564, 95% confidence interval [95% CI]: 0.523-0.607, P < .001). Longer time to VTE chemoprophylaxis (>6 h) initiation was significantly associated with VTE (OR = 1.04, 95% CI: 1.03-1.07, P < .001). This study sheds light on risk factors and chemoprophylaxis in VTE to help guide clinical practice when implementing prevention strategies in patients with burns. This knowledge can be leveraged to refine risk stratification models, inform evidence-based prevention strategies, and ultimately enhance the quality of care for patients with burns at risk of VTE.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Stanton EW, Manasyan A, Thompson CM, et al. Venous Thromboembolism Incidence, Risk Factors, and Prophylaxis in Burn Patients: A National Trauma Database Study. J Burn Care Res. 2025. PMID: 39259808. doi:10.1093/jbcr/irae171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。